Crossref
The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules
Advances in Clinical Medicine · 2026 · 16 (08) · 1142-1156
DOI: 10.12677/acm.2026.1682889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 洋 奚. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
奚, 洋. (2026). The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules. Advances in Clinical Medicine, 16(08), 1142-1156. https://doi.org/10.12677/acm.2026.1682889
Vancouver
奚 洋. The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules. Advances in Clinical Medicine. 2026;16(08):1142-1156. doi:10.12677/acm.2026.1682889
BibTeX
@article{2026,
author = {奚, 洋},
title = {The Value of Combined Serum Tumor Markers and Cancer-Associated Autoantibodies for Differentiating Benign and Malignant Pulmonary Nodules},
journal = {Advances in Clinical Medicine},
year = {2026},
volume = {16},
number = {08},
pages = {1142--1156},
doi = {10.12677/acm.2026.1682889}
}
EUVIMED